transplant

Showing 3 posts of 3 posts found.

First-of-its-kind data shows Novartis’ iscalimab extends survival of transplanted kidneys

June 6, 2019
Research and Development Novartis, iscalimab, kidney transplant, pharma, transplant

In a first-of-its-kind reveal, Novartis has presented histology data for iscalimab (CFZ533) at the American Transplant Congress (ATC) which indicates …

MSD’s antiviral drug hits endpoint targets in Phase III trials

October 20, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AiCuris, MSD, Merck, bone marrow, letermovir, transplant

MSD, known as Merck in the US, released news of the successful meeting of its primary endpoints in its Phase …

European approval for BMS kidney transplant drug Nulojix

June 22, 2011
Sales and Marketing BMS, EMA, Nulojix, transplant

European regulators have followed their US counterparts in granting marketing authorisation for a drug which aims to prevent kidney transplant …

Latest content